PharmaIN Corporation and Polypeptide Therapeutic Solutions announces a collaboration agreement for contract manufacturing

Bothell, WA & Valencia, Spain – 21st September 2018 PharmaIN Corporation and Polypeptide Therapeutic Solutions (PTS) announced today that they have entered into a collaboration agreement for contract manufacturing. Under the agreement, Polypeptide Therapeutic Solutions will provide PharmaIN contract research services and own technology to add as a part of PharmaIN´s Protected Graft Co-Polymer (PGCTM)…

Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide

Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide. Under the agreement, Polypeptide Therapeutic Solutions will use proprietary technology and research capabilities to offer contract research services from the polypeptide design up to delivery of small quantity of polymer and PMC Isochem will use…

PTS achieves GLP Certification

In December 2017 our quality control department obtained the Good Laboratory Practices (GLP) certification by the Spanish regional health authority. This allows us to carry out physicochemical studies for pharmaceutical and cosmetic products in preclinical phases. This certificate has been obtained due to our high and rigorous quality standards and is internationally recognized in all…

Novel Nanocarriers

A novel strategy developed by Aroa Duro-Castaño, Vicent J. Nebot, María J. Vicent and co-workers to produce nanosized drug carriers may improve the anticancer drug activity of polymer therapeutics and patient treatment http://onlinelibrary.wiley.com/doi/10.1002/adma.201770280/abstract